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SUMMARY. A sensitive and selective liquid chromatography-mass spectrometry (LC–MS) method for de-
termination of esomeprazole in rabbit plasma was developed and validated. After addition of midazolam
as internal standard (IS), protein precipitation by acetonitrile was used as sample preparation, and chro-
matography involved Agilent SB-C18 column (2.1 x 150 mm, 5.0 μm) using 0.1 % formic acid in water and
acetonitrile as a mobile phase with gradient elution. Detection involved positive ion mode electrospray ion-
ization (ESI), and selective ion monitoring (SIM) mode was used for quantification of target fragment ions
m/z 198 for esomeprazole and m/z 326 for midazolam (internal standard, IS). The assay was linear over the
range of 10–2000 ng/mL for esomeprazole, with a lower limit of quantitation (LLOQ) of 10 ng/mL for es-
omeprazole. Intra- and inter-day precisions were less than 14 % and the accuracies were in the range of
89.2-112.6 % for esomeprazole. This developed method was successfully applied for the determination of
esomeprazole in rabbit plasma for pharmacokinetic study.
